596114-04-4

Upstream product

• 393186-07-7 tert-butyl 2-(3-bromophenoxy)-2-methylpropanoate 
• 91687-71-7 2-(3-bromophenoxy)-2-methylpropionic acid 
• 591-20-8 3-Bromophenol 
• 393186-08-8 tert-Butyl 2-[3-(3-phthalimidopropyl)phenoxy]-2-methylpropionate 

Downstream Products

• 393186-09-9 2-{3-[3-(2,4-dinitro-benzenesulfonylamino)-propyl]-phenoxy}-2-methyl-propionic acid tert-butyl ester 
• 627097-09-0 tert-Butyl 2-[3-[3-(N-benzoxazol-2-yl)aminopropyl]phenoxy]-2-methylpropionate 

Relevant academic research and scientific papers

HPPARS ACTIVATORS

Compounds of formula (1) or a pharmaceutically acceptable salt, solvate, acid isostere, or hydrolyzable ester thereof, are disclosed. Methods of making and using the compounds are also disclosed. In particular methods for treating diseases or conditions a

Benzoxazole compound and pharmaceutical composition containing the same

The present invention is directed to a benzoxazole compound represented by the following formula (1): (wherein R1represents an alkyl group, a C6-10aryl-C1-8alkyl group, etc.; each of R2and R3, which a

Identification of a series of PPARγ/δ dual agonists via solid-Phase parallel synthesis

We have developed a general solid-phase synthesis for identification of PPAR ligands. Synthesis of a 480-member library led to the identification of a potent PPARγ/δ dual agonist 23. Compound 23 showed good plasma exposure in rats and demonstrated antihyp